Unicycive Therapeutics Ownership | Who Owns Unicycive Therapeutics?


OverviewFinancialsChart

Unicycive Therapeutics Ownership Summary


Unicycive Therapeutics is owned by 54.41% institutional investors, 6.73% insiders, and 38.85% retail investors. Vivo capital is the largest institutional shareholder, holding 9.94% of UNCY shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.81% of its assets in Unicycive Therapeutics shares.

UNCY Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockUnicycive Therapeutics54.41%6.73%38.85%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vivo capital3.47M9.94%$1.74M
Logos global management lp3.47M9.94%$1.74M
Nantahala capital management2.82M8.08%$1.41M
Vanguard group1.14M3.26%$570.36K
Geode capital management285.74K0.82%$143.18K
Goldman sachs group93.35K0.27%$46.78K
Lpl financial85.00K0.24%$42.59K
Blackrock51.84K0.15%$25.98K
State street43.94K0.13%$22.02K
Northern trust24.00K0.07%$12.03K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Vivo capital3.47M0.16%$1.74M
Logos global management lp3.47M0.14%$1.74M
Nantahala capital management2.82M0.08%$1.41M
Tandem capital management corp /adv15.50K0.00%$7.08K
Virtu financial11.09K0.00%$6.00K
Tower research capital llc (trc)18.48K0.00%$9.26K
Monashee investment management---
Bvf inc/il---
Renaissance---
Northern trust24.00K-$12.03K

Top Buyers

HolderShares% AssetsChange
Vanguard group1.14M-798.36K
Lpl financial85.00K-85.00K
Blackrock51.84K-51.84K
Geode capital management285.74K-32.55K
Tower research capital llc (trc)18.48K0.00%10.81K

Top Sellers

HolderShares% AssetsChange
Ra capital management---2.63M
Bvf inc/il---2.20M
Rosalind advisors---1.57M
Monashee investment management---1.00M
Nantahala capital management2.82M0.08%-515.23K

New Positions

HolderShares% AssetsChangeValue
Lpl financial85.00K-85.00K$42.59K
Blackrock51.84K-51.84K$25.98K
Bank of america corp /de/223.00-223.00$112.00

Sold Out

HolderChange
Wells fargo & company/mn-196.00
Redwood wealth management group-3.00K
Integrated wealth concepts-10.00K
Scientech research-10.97K
Ground swell capital-19.12K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024244.35%18,997,260-10.59%540.73%11-26.67%7250.00%
Mar 31, 20242343.75%21,247,08963.05%865.43%15114.29%2-33.33%
Dec 31, 202316-13,030,671-8.19%390.46%7-12.50%3-25.00%
Sep 30, 2023166.67%14,192,8141220.89%93187.23%814.29%4100.00%
Jun 30, 20231515.38%1,074,486-36.29%75.75%7-30.00%2100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv765.00K0.81%-
Vanguard Institutional Extnd Mkt Idx Tr373.22K0.40%-
Fidelity Extended Market Index234.56K0.25%85.08K
iShares Micro-Cap ETF65.37K0.07%-
Fidelity Series Total Market Index54.03K0.06%26.32K
Fidelity Total Market Index42.77K0.05%-
Fidelity Nasdaq Composite Index26.11K0.03%-
Spartan Extended Market Index Pool E26.07K0.03%26.07K
Northern Trust Extended Eq Market Idx22.40K0.02%-
NT Ext Equity Mkt Idx Fd - L22.40K0.02%-

Recent Insider Transactions


DateNameRoleActivityValue
May 16, 2022Schiller Brigitte Buy$12.38K

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q3--
2024 Q2--
2023 Q3--
2023 Q1--

UNCY Ownership FAQ


Who Owns Unicycive Therapeutics?

Unicycive Therapeutics shareholders are primarily institutional investors at 54.41%, followed by 6.73% insiders and 38.86% retail investors. The average institutional ownership in Unicycive Therapeutics's industry, Biotech Stocks , is 44.97%, which Unicycive Therapeutics exceeds.

Who owns the most shares of Unicycive Therapeutics?

Unicycive Therapeutics’s largest shareholders are Vivo capital (3.47M shares, 9.94%), Logos global management lp (3.47M shares, 9.94%), and Nantahala capital management (2.82M shares, 8.08%). Together, they hold 27.96% of Unicycive Therapeutics’s total shares outstanding.

Does Blackrock own Unicycive Therapeutics?

Yes, BlackRock owns 0.15% of Unicycive Therapeutics, totaling 51.84K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 25.98K$. In the last quarter, BlackRock increased its holdings by 51.84K shares, a 100.00% change.

Who is Unicycive Therapeutics’s biggest shareholder by percentage of total assets invested?

Vivo capital is Unicycive Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.16% of its assets in 3.47M Unicycive Therapeutics shares, valued at 1.74M$.

Who is the top mutual fund holder of Unicycive Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Unicycive Therapeutics shares, with 0.81% of its total shares outstanding invested in 765K Unicycive Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools